Plasbumin-5 Related Published Studies
Well-designed clinical trials related to Plasbumin-5 (Albumin)
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. [2009.09]
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. [2009.07.07]
Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. [2009.06]
Albumin versus normal saline for dehydrated term infants with metabolic acidosis due to acute diarrhea. [2009.06]
Effect of Albumin Administration Prior to Exchange Transfusion in Term Neonates with Hyperbilirubinemia A Randomized Controlled Trial. [2009.05.20]
Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial. [2009.05]
A breakfast with alpha-lactalbumin, gelatin, or gelatin + TRP lowers energy intake at lunch compared with a breakfast with casein, soy, whey, or whey-GMP. [2009.04]
The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.04]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.04]
Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. [2009.04]
Effect of megestrol acetate on serum albumin level in malnourished dialysis patients. [2009.03]
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. [2009.03]
A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. [2009.02]
Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. [2009.02]
The Effects of Dietary Patterns on Urinary Albumin Excretion: Results of the Dietary Approaches to Stop Hypertension (DASH) Trial. [2009.01.22]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. [2009.01.14]
The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study. [2009.01]
Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. [2009.01]
Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?: a prospective randomized controlled trial. [2008.11]
Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study. [2008.11]
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. [2008.09]
Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. [2008.09]
Effect of different albumin concentrations in extracorporeal circuit prime on perioperative fluid status in young children. [2008.09]
Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial. [2008.09]
Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension. [2008.09]
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. [2008.08]
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. [2008.08]
Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?: a prospective randomized controlled trial. [2008.07.22]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. [2008.07]
Effect of maternal egg consumption on breast milk ovalbumin concentration. [2008.07]
Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. [2008.06]
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [2008.06]
HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. [2008.06]
An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. [2008.06]
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. [2008.06]
Effect of zinc supplementation on microalbuminuria in patients with type 2 diabetes: a double blind, randomized, placebo-controlled, cross-over trial. [2008.06]
Usefulness of bilirubin/ albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. [2008.05.01]
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. [2008.05]
Telemedicine home blood pressure measurements and progression of albuminuria in elderly people with diabetes. [2008.05]
Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients. [2008.05]
The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness. [2008.04.30]
Effects of alpha-lactalbumin-enriched formula containing different concentrations of glycomacropeptide on infant nutrition. [2008.04]
Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. [2008.04]
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [2008.03.19]
HES 130/0.4 (Voluven(R)) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. [2008.03.13]
Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. [2008.03]
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. [2008.03]
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study. [2008.03]
A comparison of albumin-bolus therapy versus normal saline-bolus therapy for hypotension in neonates. [2008.01]
Serum transforming growth factor-beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone. [2008.01]
The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness. [2008]
Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. [2008]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: A pilot open, randomized, and controlled clinical trial. [2007.12.27]
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. [2007.12]
Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. [2007.12]
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects. [2007.12]
Rosiglitazone decreases albuminuria in type 2 diabetic patients. [2007.12]
Role of albumin coating of tympanostomy tubes: long-term clinical evaluation. [2007.12]
Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy. [2007.11]
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus. [2007.11]
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. [2007.10]
Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus. [2007.10]
Albumin synthesis in premature neonates is stimulated by parenterally administered amino acids during the first days of life. [2007.10]
Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria. [2007.10]
Effects of albumin 5% and artificial colloids on clot formation in small infants. [2007.10]
The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study. [2007.10]
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus. [2007.09]
A randomized clinical trial comparing recombinant hyaluronan/recombinant albumin versus human tubal fluid for cleavage stage embryo transfer in patients with multiple IVF-embryo transfer failure. [2007.09]
N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect. [2007.09]
Saline or albumin for fluid resuscitation in patients with traumatic brain injury. [2007.08.30]
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: Results of the IMPROVE trial. [2007.08.01]
Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients. [2007.08]
Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids. [2007.08]
The albumin in acute stroke trial (ALIAS); design and methodology. [2007.08]
Humoral immune responses in the horse after intrathecal challenge with ovalbumin. [2007.07]
Nutrient ingestion, protein intake, and sex, but not age, affect the albumin synthesis rate in humans. [2007.07]
Effects of alpha-lactalbumin on emotional processing in healthy women. [2007.07]
Hyaluronic acid versus albumin in human embryo transfer medium. [2007.07]
Albumin therapy in acute stroke patients. [2007.07]
Effect of intravenous albumin infusion on brain salicylate concentration. [2007.06]
[Comparative study of hospital costs associated with human albumin 20% (Vialebex 20%) or polygeline as a fluid resuscitation strategy for cirrhotic ascites] [2007.06]
Impact of weight change on albuminuria in the general population. [2007.06]
Beta2-microglobulin removal and plasma albumin levels with high cut-off hemodialysis. [2007.05]
The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients. [2007.05]
Exercise improves albumin fractional synthetic rate in chronic hemodialysis patients. [2007.05]
Commentary: Saline versus Albumin Fluid Evaluation (SAFE) Investigators (2006). Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. [2007.05]
Effect of Intravenous Albumin Infusion on Brain Salicylate Concentration. [2007.04.20]
Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus. [2007.02.01]
A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor. [2007]
A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery. [2007]
The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. [2006.12]
Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy. [2006.12]
The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. [2006.12]
Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. [2006.12]
Comparison of hemodynamic changes after acute normovolemic hemodilution using Ringer's lactate versus 5% albumin in patients on beta-blockers undergoing coronary artery bypass surgery. [2006.12]
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects. [2006.11.30]
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. [2006.11.18]
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. [2006.11]
Effects of bovine alpha-lactalbumin and casein glycomacropeptide-enriched infant formulae on faecal microbiota in healthy term infants. [2006.11]
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients. [2006.11]
Concurrent expansion of plasma volume and left ventricular end-diastolic volume in patients after rapid infusion of 5% albumin and lactated Ringer's solution. [2006.11]
|
